Bio-Rad Laboratories, Inc. (BIO) Gross margin 2016–2025
Bio-Rad Laboratories, Inc. (BIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
51.9%FY2025 · since FY2016: 55.0% → 51.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 51.9% | -1.9 pp |
| FY2024 | 53.7% | +0.3 pp |
| FY2023 | 53.4% | -2.5 pp |
| FY2022 | 55.9% | -0.1 pp |
| FY2021 | 56.1% | -0.4 pp |
| FY2020 | 56.5% | +2.1 pp |
| FY2019 | 54.4% | +0.9 pp |
| FY2018 | 53.4% | -1.6 pp |
| FY2017 | 55.0% | -0.1 pp |
| FY2016 | 55.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice